Edem Binka

Dr. Raza A. Patel received his master's degree in public health and his medical degree at the University Of Utah School Of Medicine. He completed his pediatric residency and fellowship in pediatric gastroenterology at SUNY at Buffalo at the Women and Children ́s Hospital of Buffalo. Dr. Patel is board-certified in Pediatrics and Pediatric Gastroenterology and has been clinical faculty at the University of Utah since 2011. Dr. Patel is an Assistant Professor (Clinical) of Pediatrics at the University of Utah and is director of the Pediatric Endoscopy Unit where he provides advanced endoscopic diagnostic and therapeutic procedures. He also staffs the Esophageal and Airway Center. His clinical and research interests include esophageal diseases and disorders. He has published many gastroenterology journal articles and book chapters.

Dr. Raoul Nelson received his medical degree and doctorate of philosophy from the Molecular Program at Washington University School of Medicine in St. Louis, completed his Pediatric residency at University of Utah and Primary Children's Medical Center, and completed his Nephrology Fellowship at St. Louis Children's Hospital at Washington University in St. Louis. He is currently a Professor in the Nephrology & Hypertension division at University of Utah and is board-certified in Pediatric Nephrology. He is Chief of the Division of Pediatric Nephrology & Hypertension and Medical Director of Pediatric Dialysis. His research interests have included collecting duct physiology and pathophysiology, kidney development, and cystic kidney disease. He has created a number of transgenic mouse models expressing green fluorescent protein and Cre recombinase within intercalated and principal cells of the renal collecting duct. The Cre expression mouse models have been used to knockout genes from the renal collecting duct in studies of polycystic kidney disease, hypertension, kidney development and collecting duct physiology. The green fluorescent protein expressing mice were used to develop the COPAS technique for isolation of tubules for molecular analysis and perform systems biology studies of gene expression within intercalated cells of the kidney. He has also studied transcription factor regulation of collecting development and transport. Finally, he has contributed to several genetic studies of tubular disorders of the kidney including renal tubular acidosis. He now is now transitioning to clinical research and is recruiting pediatric and adolescent patients to participate in multicenter studies as part of the Midwestern Pediatric Nephrology Research Consortium. These studies aim to define the natural history and explore treatments for kidney disease in pediatric and adolescent patients. Currently he is a co-Principal Investigator for a collaborative study of genetics and biomarkers in pediatric and adolescent IgA nephropathy and Henoch-Schonlein Purpura that will use GWAS and WES to identify novel genetic loci involved in the pathogenesis of disease. He is also a co-investigator in a study of nephrolithiasis in pediatric and adolescent patients that is under development that will investigate new approaches to treatment and also have a biological repository for future studies. He has completed a pilot study of HPV vaccine in chronic kidney disease, dialysis and transplant patients compared to healthy controls. He is also local principal investigator for randomized and open label trials of cinecalcet in treatment of patients ages 6 to < 18 years of age on dialysis with secondary hyperparathyroidism. He is also a local principal investigator for a clinical trial of azilsartan in patients ages 6 to < 18 years of age with hypertension. Such drug trials are designed to obtain FDA labeling for pediatric indication for use. The overall goal is to make contributions to improve care of renal disease in pediatric and adolescent patients.

Dr. John C. Carey is a distinguished Professor Emeritus in the Department of Pediatrics at the University of Utah, specializing in medical genetics and pediatric genetics. His extensive career includes leadership roles, research in congenital malformations, and contributions to medical literature, including co-authoring a widely used textbook in the field. As a founding professional advisor for the Support Organization for Trisomy 18, 13, and Related Disorders (SOFT), Dr. Carey remains committed to addressing the medical and ethical aspects of care for infants and children with significant genetic conditions. With over 300 published works, he continues to play a vital role in mentoring future genetics professionals through established fellowship programs at the University of Utah. Generated from the website